Results 11 to 20 of about 5,245,251 (341)

Sex differences in antiplatelet therapy: state-of-the art

Platelets, 2023
Antiplatelet therapy is a cornerstone of secondary prevention of cardiovascular diseases (CVDs). However, current guidelines are based on data derived primarily from men, as women are generally underrepresented in trials.
A. Gąsecka, J. Zimodro, Y. Appelman
semanticscholar   +1 more source

Comparison of the continuation and discontinuation of perioperative antiplatelet therapy in laparoscopic surgery for colorectal cancer: A retrospective, multicenter, observational study (YCOG 1603)

Annals of Gastroenterological Surgery, 2021
Aim The present study aimed to examine the effect of continuing antiplatelet therapy in the perioperative period for patients undergoing laparoscopic resection for colorectal cancer who had received preoperative antiplatelet therapy.
Hiroki Ohya, Jun Watanabe, Yusuke Suwa, Kazuya Nakagawa, Hirokazu Suwa, Mayumi Ozawa, Atsushi Ishibe, Chikara Kunisaki, Itaru Endo   +8 more
doaj   +1 more source

DENTAL MANAGEMENT AND BLEEDING COMPLICATIONS OF PATIENTS ON LONG-TERM ORAL ANTIPLATELET THERAPY. REVIEW OF EXISTING STUDIES AND GUIDELINES. [PDF]

Journal of IMAB, 2013
Antiplatelet drugs are currently widely used in primary and especially secondary prevention of cardiovascular events. Dental management of patients on antiplatelet therapy is still not clearly defined: the discontinuation of antiplatelet therapy ...
Atanaska Dinkova, Donka G. Kirova, Delyan Delev   +2 more
doaj   +1 more source

[2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.]

Kardiologia polska, 2018
The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC)and of the European Association for Cardio-Thoracic Surgery(EACTS)
M. Valgimigli, H. Bueno, R. Byrne, J. Collet, F. Costa, A. Jeppsson, P. Jüni, A. Kastrati, P. Kolh, L. Mauri, G. Montalescot, F. Neumann, Mate Peticevic, M. Roffi, P. Steg, S. Windecker, J. Zamorano   +16 more
semanticscholar   +3 more sources

Antiplatelet therapy and long-term mortality in patients with myocardial injury after non-cardiac surgery

Open Heart, 2023
Backgrounds Myocardial injury after non-cardiac surgery (MINS) has recently been accepted as a common complication associated with increased mortality. However, little is known about the treatment of MINS.
Seung-Hwa Lee, Seung Woo Park, Jihoon Kim, Sang-Chol Lee, Jungchan Park, Ji-hye Kwon, Kwangmo Yang, Jong Hwan Lee, Jeong Jin Min   +8 more
doaj   +1 more source

Effects of Periprocedural Tirofiban vs. Oral Antiplatelet Drug Therapy on Posterior Circulation Infarction in Patients With Acute Intracranial Atherosclerosis-Related Vertebrobasilar Artery Occlusion

Frontiers in Neurology, 2020
Background and purpose: Tirofiban and oral antiplatelet drugs can be used to inhibit reocclusion and restore microvascular reperfusion during endovascular treatment (EVT).
Xuan Sun, Huijun Zhang, Xu Tong, Feng Gao, Gaoting Ma, Zhongrong Miao   +5 more
doaj   +1 more source

Antiplatelet therapy after percutaneous coronary intervention.

EuroIntervention, 2022
Antiplatelet therapy is key to reducing local thrombotic complications and systemic ischaemic events among patients undergoing percutaneous coronary interventions (PCI), but it is inevitably associated with increased bleeding.
D. Angiolillo, M. Galli, J. Collet, A. Kastrati, M. O’Donoghue   +4 more
semanticscholar   +1 more source

Antiplatelet therapy in cardiovascular disease: Current status and future directions

British Journal of Clinical Pharmacology, 2022
Antiplatelet medications remain a cornerstone of therapy for atherosclerotic cardiovascular and cerebrovascular diseases. In primary prevention (patients with cardiovascular risk factors but no documented events, symptoms or angiographic disease), there ...
G. Passacquale, Pankaj Sharma, D. Perera, A. Ferro   +3 more
semanticscholar   +1 more source

Artificial Intelligence and Neurosurgery: Tracking Antiplatelet Response Patterns for Endovascular Intervention

Medicina, 2023
Platelets play a critical role in blood clotting and the development of arterial blockages. Antiplatelet therapy is vital for preventing recurring events in conditions like coronary artery disease and strokes.
Khushi Saigal, Anmol Bharat Patel, Brandon Lucke-Wold   +2 more
doaj   +1 more source

Edoxaban Versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism After TAVR: The ADAPT-TAVR Randomized Clinical Trial

Circulation, 2022
Background: It is unknown whether the direct oral anticoagulant edoxaban can reduce leaflet thrombosis and the accompanying cerebral thromboembolic risk after transcatheter aortic valve replacement.
Duk‐Woo Park, Jung‐Min Ahn, D. Kang, Kyung-Won Kim, H. Koo, D. Yang, S. Jung, Byungjun Kim, Y. Wong, C. Lam, W. Yin, Jeng Wei, Yung-Tsai Lee, H. Kao, Mao-Shin Lin, Tsung-Yu Ko, Won-Jang Kim, S. Kang, S. Yun, Seung-Ah Lee, Euihong Ko, Hanbit Park, Dae-Hee Kim, Joon-Won Kang, Jae-Hong Lee, Seung‐Jung Park   +25 more
semanticscholar   +1 more source